Product Classification
- drug impurity
- drug standards
- Metaraminol bitartrate
- analytical chemistry
- standard substances
- chemical custom synthesis
- Azithromycin
- Atorvastatin
- (S)-Cinacalcet
- Ilaprazole
- Tranexamic Acid
- Duloxetine
- Octreotide
- Budesonide
- Carboprost Trometamol
- Minocycline
- Dobutamine
- Netupitant
- Axitinib
- Omadacycline
- Brivaracetam
- Metoprolol
- Indobufen
- Empagliflozin
- Dapagliflozin
- Acetylcysteine
- Hydroxychloroquine
- Tegoprazan
- Lenalidomide
- Canagliflozin
- Bromocriptine
- Rasagiline
- Bortezomib
- Diclofenac
- Bisoprolol
- Rocuronium Bromide
- Esmolol
- Bromhexine
- Probucol
- Formoterol
- Crisaborole
- Pitavastatin (3S,5S)-Isomer Calcium
- Bumetanide
- Dotinurad
- Fulvestrant
- Dotinurad
- Landiolol
Contact us
Tel:+86 17320513646
Phone:+86 17320513646
Website:https://www.moxinchem.com
Email: mike@molcoo.com
Address:Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China

28328-54-3
- Product Name:Bumetanide EP Impurity B
- Molecular Formula:C13H12 N2 O5 S
- Purity:99%
- Molecular Weight:308.315
Product Details;
CasNo: 28328-54-3
Molecular Formula: C13H12 N2 O5 S
Reputable supplier selling Bumetanide EP Impurity B 28328-54-3 with stock
- Molecular Formula:C13H12 N2 O5 S
- Molecular Weight:308.315
- Vapor Pressure:3.65E-13mmHg at 25°C
- Boiling Point:555.3°Cat760mmHg
- PKA:3.91±0.10(Predicted)
- Flash Point:289.6°C
- PSA:141.09000
- Density:1.512g/cm3
- LogP:3.76900
3-amino-5-(aminosulphonyl)-4-phenoxybenzoic acid(Cas 28328-54-3) Usage
InChI:InChI=1/C13H12N2O5S/c14-10-6-8(13(16)17)7-11(21(15,18)19)12(10)20-9-4-2-1-3-5-9/h1-7H,14H2,(H,16,17)(H2,15,18,19)
28328-54-3 Relevant articles
Synthesis method of intermediate of bumetanib
-
, (2021/12/07)
The invention discloses a synthesis meth...
ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE
-
Page/Page column 118, (2012/02/15)
The present invention provides acylsulfo...
SUBSTITUTED ANTHRANILIC ACIDS
-
Page/Page column 28, (2008/12/04)
Disclosed herein are substituted anthran...
Compounds for treating hypertension
-
, (2008/06/13)
Compounds of the formula STR1 and their ...
28328-54-3 Process route
-
-
28395-11-1
3-benzylamino-4-phenoxy-5-sulphamyl-benzoic acid

-
-
28328-54-3
3-amino-5-(aminosulfonyl)-4-phenoxybenzoic acid
Conditions | Yield |
---|---|
With
2,3-dicyano-5,6-dichloro-p-benzoquinone;
In
acetonitrile;
at 60 ℃;
for 3h;
Reagent/catalyst;
Temperature;
|
89% |
-
-
32633-10-6
3-(4-Methoxy-benzylamino)-4-phenoxy-5-sulfamoyl-benzoesaeure

-
-
28328-54-3
3-amino-5-(aminosulfonyl)-4-phenoxybenzoic acid
Conditions | Yield |
---|---|
With
ammonium cerium (IV) nitrate;
In
acetonitrile;
at 0 - 5 ℃;
for 10h;
Reagent/catalyst;
Temperature;
|
78% |
28328-54-3 Upstream products
-
3-nitro-4-phenoxy-5-sulfamoylbenzoic acid
-
3-amino-4-phenoxy-5-sulphamyl-benzamide
-
phenol
-
4-chloro-3-nitro-5-sulfamoylbenzoic acid
28328-54-3 Downstream products
-
ethyl-4-phenoxy-3-propargylamino-5-sulphamyl-benzoate
-
4-phenoxy-3-propargylamino-5-sulphamyl-benzoic acid
-
ethyl-3-allylamino-4-phenoxy-5-sulphamyl-benzoate
-
PF-1659
Related products
-
Ilaprazole ImpurityDetail
CAS:172152-35-1
$ -
Acetylcysteine ImpurityDetail
CAS:15312-11-5
$ -
Pitavastatin (3S,5S)-Isomer CalciumDetail
CAS:254452-92-1
$ -
Dotinurad ImpurityDetail
CAS:1285573-47-8
$